{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:13:57Z","timestamp":1794035637657,"version":"4.8.0"},"reference-count":308,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Sepsis is a life-threatening clinical syndrome characterized by multiorgan dysfunction caused by a dysregulated or over-reactive host response to infection. During sepsis, the coagulation cascade is triggered by activated cells of the innate immune system, such as neutrophils and monocytes, resulting in clot formation mainly in the microcirculation, a process known as immunothrombosis. Although this process aims to protect the host through inhibition of the pathogen\u2019s dissemination and survival, endothelial dysfunction and microthrombotic complications can rapidly lead to multiple organ dysfunction. The development of treatments targeting endothelial innate immune responses and immunothrombosis could be of great significance for reducing morbidity and mortality in patients with sepsis. Medications modifying cell-specific immune responses or inhibiting platelet\u2013endothelial interaction or platelet activation have been proposed. Herein, we discuss the underlying mechanisms of organ-specific endothelial dysfunction and immunothrombosis in sepsis and its complications, while highlighting the recent advances in the development of new therapeutic approaches aiming at improving the short- or long-term prognosis in sepsis.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1144229","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T01:28:12Z","timestamp":1680571692000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":202,"title":["Endothelial dysfunction and immunothrombosis in sepsis"],"prefix":"10.3389","volume":"14","author":[{"given":"Eleni","family":"Maneta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evmorfia","family":"Aivalioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Tual-Chalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besa","family":"Emini Veseli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Gatsiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Stamatelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Stellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama"},{"key":"B2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15265","article-title":"Platelet fc\u03b3riia in immunity and thrombosis: Adaptive immunothrombosis","volume":"19","author":"Patel","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/imr.12912","article-title":"Intracellular innate immune receptors: Life inside the cell","volume":"297","author":"Kanneganti","year":"2020","journal-title":"Immunol Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2017","journal-title":"Thromb Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2006.02.003","article-title":"Factor xiii in severe sepsis and septic shock","volume":"119","author":"Zeerleder","year":"2007","journal-title":"Thromb Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/1076029613492875","article-title":"Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin","volume":"20","author":"Hoppensteadt","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"B9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijid.2005.06.001","article-title":"And antithrombin levels are predictive of poor outcome in gram-negative sepsis caused by burkholderia pseudomallei","volume":"10","author":"LaRosa","year":"2006","journal-title":"Int J Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136463","article-title":"Assessment of fibrinolysis in sepsis patients with urokinase modified thromboelastography","volume":"10","author":"Panigada","year":"2015","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2011.05.006","article-title":"Severe protein c deficiency is associated with organ dysfunction in patients with severe sepsis","volume":"26","author":"Shaw","year":"2011","journal-title":"J Crit Care"},{"key":"B12","article-title":"Disseminated intravascular coagulation","volume-title":"Statpearls","author":"Costello","year":"2022"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.118.312130","article-title":"Intrinsic pathway of coagulation and thrombosis","volume":"39","author":"Grover","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.46.1.103","article-title":"Tissue factor pathway inhibitor and the revised theory of coagulation","volume":"46","author":"Broze","year":"1995","journal-title":"Annu Rev Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-2007-995819","article-title":"Antithrombin: Its physiological importance and role in dic","volume":"24","author":"Mammen","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1161\/01.Atv.0000134298.25489.92","article-title":"Thrombomodulin-protein c-epcr system: Integrated to regulate coagulation and inflammation","volume":"24","author":"Van de Wouwer","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(19)68566-2","article-title":"Regulation of activated protein c by protein s. The role of phospholipid in factor va inactivation","volume":"256","author":"Walker","year":"1981","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)81051-7","article-title":"Kinetics of the activation of plasminogen by human tissue plasminogen activator","volume":"257","author":"Hoylaerts","year":"1982","journal-title":"Role Fibrin J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.2.381.381","article-title":"Plasminogen activator inhibitors","volume":"69","author":"Sprengers","year":"1987","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201910-1911TR","article-title":"Endothelial responses in sepsis","volume":"202","author":"Joffre","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: Challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2010229117","article-title":"Il-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome","volume":"117","author":"Kang","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000171805.24799.fa","article-title":"Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines","volume":"96","author":"Szotowski","year":"2005","journal-title":"Circ Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2021.07.005","article-title":"Adenosine-to-Inosine alu rna editing controls the stability of the pro-inflammatory long noncoding rna Neat1 in atherosclerotic cardiovascular disease","volume":"160","author":"Vlachogiannis","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107909","article-title":"Pattern recognition receptors as therapeutic targets for bacterial, viral and fungal sepsis","volume":"98","author":"Yuki","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.08.028","article-title":"Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis","volume":"88","author":"Amalakuhan","year":"2016","journal-title":"Cytokine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.3.9705034","article-title":"Elevated circulating e-selectin, intercellular adhesion molecule 1, and Von willebrand factor in patients with severe infection","volume":"157","author":"Kayal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.vascn.2017.10.004","article-title":"Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia","volume":"89","author":"van Poelgeest","year":"2018","journal-title":"J Pharmacol Toxicol Methods"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.10.001","article-title":"Exocytosis of endothelial lysosome-related organelles hair-triggers a patchy loss of glycocalyx at the onset of sepsis","volume":"186","author":"Zullo","year":"2016","journal-title":"Am J Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx023","article-title":"Endothelial glycocalyx breakdown is mediated by angiopoietin-2","volume":"113","author":"Lukasz","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B35","article-title":"[the study of the mechanism of the effect of heparin on tissue perfusion of sepsis patients]","volume":"20","author":"Yang","year":"2008","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14371","article-title":"Derangement of the endothelial glycocalyx in sepsis","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy167","article-title":"A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation","volume":"114","author":"Yang","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/cvr\/cvaa070","article-title":"The effects of sepsis on endothelium and clinical implications","volume":"117","author":"Dolmatova","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/08850666221109186","article-title":"Biomarkers of glycocalyx injury and endothelial activation are associated with clinical outcomes in patients with sepsis: A systematic review and meta-analysis","volume":"38","author":"Fern\u00e1ndez-Sarmiento","year":"2023","journal-title":"J Intensive Care Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13054-021-03545-1","article-title":"Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-Phosphate and soluble ve-cadherin: A substudy of albios","volume":"25","author":"Piotti","year":"2021","journal-title":"Crit Care"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.01.019","article-title":"Plasma syndecan-1 is associated with fluid requirements and clinical outcomes in emergency department patients with sepsis","volume":"42","author":"Saoraya","year":"2021","journal-title":"Am J Emerg Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00013-2017","article-title":"High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis","volume":"50","author":"Mangat","year":"2017","journal-title":"Eur Respir J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000198525.82124.74","article-title":"Endocan, a new endothelial marker in human sepsis","volume":"34","author":"Scherpereel","year":"2006","journal-title":"Crit Care Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/jci97488","article-title":"Tie2 protects the vasculature against thrombus formation in systemic inflammation","volume":"128","author":"Higgins","year":"2018","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000001853","article-title":"Elevated plasma angiopoietin-2 levels are associated with fluid overload, organ dysfunction, and mortality in human septic shock","volume":"44","author":"Fisher","year":"2016","journal-title":"Crit Care Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1177\/1076029618786029","article-title":"Angiopoietin 2 levels in the risk stratification and mortality outcome prediction of sepsis-associated coagulopathy","volume":"24","author":"Statz","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"B47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13054-021-03474-z","article-title":"Angiopoietin-2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure","volume":"25","author":"Yu","year":"2021","journal-title":"Crit Care"},{"key":"B48","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1186\/cc9020","article-title":"Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity","volume":"14","author":"Davis","year":"2010","journal-title":"Crit Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/SHK.0b013e3181ec71ab","article-title":"Acute endotoxemia inhibits microvascular nitric oxide-dependent vasodilation in humans","volume":"35","author":"Engelberger","year":"2011","journal-title":"Shock"},{"key":"B50","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/cc7720","article-title":"Pulmonary vascular permeability changes in an ovine model of methicillin-resistant staphylococcus aureus sepsis","volume":"13","author":"Jonkam","year":"2009","journal-title":"Crit Care"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000186414.86162.03","article-title":"Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis","volume":"33","author":"Soriano","year":"2005","journal-title":"Crit Care Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13054-022-04075-0","article-title":"A new perspective on no pathway in sepsis and adma lowering as a potential therapeutic approach","volume":"26","author":"Singh","year":"2022","journal-title":"Crit Care"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1055\/a-1914-2094","article-title":"Beta-Secretase-1 antisense rna is associated with vascular ageing and atherosclerotic cardiovascular disease","volume":"122","author":"Bampatsias","year":"2022","journal-title":"Thromb Haemost"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1721144","article-title":"Circulating amyloid beta 1-40 is associated with increased rate of progression of atherosclerosis in menopause: A prospective cohort study","volume":"121","author":"Lambrinoudaki","year":"2021","journal-title":"Thromb Haemost"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa548","article-title":"Clinical value of amyloid-Beta1-40 as a marker of thrombo-inflammation in antiphospholipid syndrome","volume":"60","author":"Tektonidou","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.12.033","article-title":"The alzheimer's disease amyloid-beta hypothesis in cardiovascular aging and disease: Jacc focus seminar","volume":"75","author":"Stakos","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.06.027","article-title":"Amyloid-beta (1-40) peptide and subclinical cardiovascular disease","volume":"72","author":"Stamatelopoulos","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15852","article-title":"Intracellular communication and immunothrombosis in sepsis","volume":"20","author":"Iba","year":"2022","journal-title":"J Thromb Haemost"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063065","article-title":"The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates endothelial inflammation and microvascular thrombosis in a sepsis mouse model","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1172\/jci141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in covid-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J Clin Invest"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa268","article-title":"Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic system","volume":"117","author":"Liberale","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.118.311150","article-title":"Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1\u03b1 and cathepsin G","volume":"38","author":"Folco","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/srep25171","article-title":"Tissue factor is induced by interleukin-33 in human endothelial cells: A new link between coagulation and inflammation","volume":"6","author":"Stojkovic","year":"2016","journal-title":"Sci Rep"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2005.01.013","article-title":"Detached endothelial cells and microparticles as sources of tissue factor activity","volume":"116","author":"Kushak","year":"2005","journal-title":"Thromb Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01205.x","article-title":"Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: Implications for the pathophysiology of hemolytic uremic syndrome","volume":"3","author":"Nestoridi","year":"2005","journal-title":"J Thromb Haemost"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/01.Ccm.0000104941.89570.5f","article-title":"Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: Impact of endotoxin and tumor necrosis factor-alpha","volume":"32","author":"Muth","year":"2004","journal-title":"Crit Care Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.15.5.612","article-title":"Transcriptional regulation of tissue factor expression in human endothelial cells","volume":"15","author":"Parry","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.18.7095","article-title":"Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression","volume":"87","author":"Key","year":"1990","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.5.1467.1467","article-title":"Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo","volume":"72","author":"van Hinsbergh","year":"1988","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.12.4533","article-title":"Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1","volume":"83","author":"Bevilacqua","year":"1986","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)61204-7","article-title":"Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of escherichia coli sepsis","volume":"167","author":"Lupu","year":"2005","journal-title":"Am J Pathol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-205914","article-title":"Activation of endothelial intrinsic nf-{Kappa}B pathway impairs protein c anticoagulation mechanism and promotes coagulation in endotoxemic mice","volume":"114","author":"Song","year":"2009","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071393","article-title":"Divergent roles of endothelial nf-kappab in multiple organ injury and bacterial clearance in mouse models of sepsis","volume":"205","author":"Ye","year":"2008","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1097\/01.Ta.0000054652.38788.5a","article-title":"Alterations in endothelial thrombomodulin expression in zymosan-induced lung injury","volume":"54","author":"Cone","year":"2003","journal-title":"J Trauma"},{"key":"B75","article-title":"Expression of tissue factor, thrombomodulin, and e-selectin in baboons with lethal escherichia coli sepsis","volume":"142","author":"Drake","year":"1993","journal-title":"Am J Pathol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200108093450603","article-title":"Dysfunction of endothelial protein c activation in severe meningococcal sepsis","volume":"345","author":"Faust","year":"2001","journal-title":"N Engl J Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jcrc.2017.07.049","article-title":"Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis","volume":"43","author":"Ikeda","year":"2018","journal-title":"J Crit Care"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.9.1619","article-title":"The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity","volume":"185","author":"Tedesco","year":"1997","journal-title":"J Exp Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12959-022-00384-0","article-title":"Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial Stat3 to promote the development of arterial thrombosis","volume":"20","author":"Chen","year":"2022","journal-title":"Thromb J"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-015-8628-2","article-title":"Organ distribution of histones after intravenous infusion of fitc histones or after sepsis","volume":"61","author":"Fattahi","year":"2015","journal-title":"Immunol Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/art.39239","article-title":"Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps","volume":"67","author":"Huang","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v100.2.517","article-title":"C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils","volume":"100","author":"Wojta","year":"2002","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb Haemost"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.2.579","article-title":"Platelet activation by C1q results in the induction of alpha Iib\/Beta 3 integrins (Gpiib-iiia) and the expression of p-selectin and procoagulant activity","volume":"178","author":"Peerschke","year":"1993","journal-title":"J Exp Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)37872-4","article-title":"Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or Von willebrand factor to newly expressed cell surface gpiib-iiia","volume":"263","author":"Ando","year":"1988","journal-title":"J Biol Chem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V68.4.875.875","article-title":"Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase","volume":"68","author":"Wiedmer","year":"1986","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1084\/jem.158.2.603","article-title":"Human platelet activation by C3a and C3a des-arg","volume":"158","author":"Polley","year":"1983","journal-title":"J Exp Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1172\/jci109269","article-title":"C5 chemotactic fragment induces leukocyte production of tissue factor activity: A link between complement and coagulation","volume":"63","author":"Muhlfelder","year":"1979","journal-title":"J Clin Invest"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1706818114","article-title":"Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of escherichia coli sepsis","volume":"114","author":"Keshari","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/srep42714","article-title":"Complement component 5 promotes lethal thrombosis","volume":"7","author":"Mizuno","year":"2017","journal-title":"Sci Rep"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-269746","article-title":"Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of escherichia coli sepsis","volume":"116","author":"Silasi-Mansat","year":"2010","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)61133-9","article-title":"Anti-C5a ameliorates Coagulation\/Fibrinolytic protein changes in a rat model of sepsis","volume":"160","author":"Laudes","year":"2002","journal-title":"Am J Pathol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2003.09.018","article-title":"Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor","volume":"111","author":"Liebman","year":"2003","journal-title":"Thromb Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.chest.2017.01.010","article-title":"Endothelial permeability and hemostasis in septic shock: Results from the process trial","volume":"152","author":"Hou","year":"2017","journal-title":"Chest"},{"key":"B97","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1055\/s-0034-1398377","article-title":"Profound endothelial damage predicts impending organ failure and death in sepsis","volume":"41","author":"Johansen","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"B98","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13054-017-1815-x","article-title":"Markers of acute kidney injury in patients with sepsis: The role of soluble thrombomodulin","volume":"21","author":"Katayama","year":"2017","journal-title":"Crit Care"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-2222","article-title":"Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1177\/1076029609344981","article-title":"Tissue factor pathway inhibitor and p-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy","volume":"17","author":"Mosad","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"B101","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40560-017-0238-8","article-title":"Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis","volume":"5","author":"Hoshino","year":"2017","journal-title":"J Intensive Care"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1186\/cc2459","article-title":"Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [Isrctn74215569]","volume":"8","author":"Kinasewitz","year":"2004","journal-title":"Crit Care"},{"key":"B103","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13054-015-0918-5","article-title":"Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: A prospective study","volume":"19","author":"Ostrowski","year":"2015","journal-title":"Crit Care"},{"key":"B104","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","article-title":"Activation of the Jak\/Stat3 and Pi3k\/Akt pathways are crucial for il-6 trans-Signaling-Mediated pro-inflammatory response in human vascular endothelial cells","volume":"16","author":"Zegeye","year":"2018","journal-title":"Cell Commun Signal"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2111","article-title":"Hemolytic uremic syndrome-associated shiga toxins promote endothelial-cell secretion and impair Adamts13 cleavage of unusually Large Von willebrand factor multimers","volume":"106","author":"Nolasco","year":"2005","journal-title":"Blood"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201811-2111OC","article-title":"A novel assay for neutrophil extracellular trap formation independently predicts disseminated intravascular coagulation and mortality in critically ill patients","volume":"200","author":"Abrams","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/nm1565","article-title":"Platelet Tlr4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.677902","article-title":"Tissue factor-enriched neutrophil extracellular traps promote immunothrombosis and disease progression in sepsis-induced lung injury","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-624023","article-title":"P-selectin promotes neutrophil extracellular trap formation in mice","volume":"126","author":"Etulain","year":"2015","journal-title":"Blood"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3A0415-161R","article-title":"Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets","volume":"99","author":"Carestia","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12710","article-title":"Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps","volume":"12","author":"Maugeri","year":"2014","journal-title":"J Thromb Haemost"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1038\/s41598-018-20479-x","article-title":"Deep vein thrombosis in mice is regulated by platelet Hmgb1 through release of neutrophil-extracellular traps and DNA","volume":"8","author":"Dyer","year":"2018","journal-title":"Sci Rep"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-516484","article-title":"Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation","volume":"123","author":"Rossaint","year":"2014","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2847","article-title":"Infection-induced netosis is a dynamic process involving neutrophil multitasking in vivo","volume":"18","author":"Yipp","year":"2012","journal-title":"Nat Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11037","article-title":"Coagulation induced by C3ar-dependent netosis drives protumorigenic neutrophils during small intestinal tumorigenesis","volume":"7","author":"Guglietta","year":"2016","journal-title":"Nat Commun"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.653228","article-title":"Review: The emerging role of neutrophil extracellular traps in sepsis and sepsis-associated thrombosis","volume":"11","author":"Chen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105626","article-title":"Endothelial dysfunction induced by extracellular neutrophil traps plays important role in the occurrence and treatment of extracellular neutrophil traps-related disease","volume":"23","author":"Yu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.116.307634","article-title":"Neutrophil extracellular traps promote angiogenesis: Evidence from vascular pathology in pulmonary hypertension","volume":"36","author":"Aldabbous","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00591-7","article-title":"Potentiation of nets release is novel characteristic of trem-1 activation and the pharmacological inhibition of trem-1 could prevent from the deleterious consequences of nets release in sepsis","volume":"18","author":"Boufenzer","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13578-022-00845-z","article-title":"Neutrophil extracellular traps promote thrombogenicity in cerebral venous sinus thrombosis","volume":"12","author":"Jin","year":"2022","journal-title":"Cell Biosci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.10.012","article-title":"Extracellular histones induce tissue factor expression in vascular endothelial cells Via tlr and activation of nf-\u03bab and ap-1","volume":"137","author":"Yang","year":"2016","journal-title":"Thromb Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: A predominant role of histones","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PloS One"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.07.005","article-title":"Inhibition of peptidylarginine deiminase alleviates lps-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia","volume":"833","author":"Liang","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.07.069","article-title":"Citrullinated histone 3 causes endothelial barrier dysfunction","volume":"503","author":"Meegan","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1055\/a-1530-3980","article-title":"The proteolytic inactivation of protein z-dependent protease inhibitor by neutrophil elastase might promote the procoagulant activity of neutrophil extracellular traps in sepsis","volume":"122","author":"Bianchini","year":"2022","journal-title":"Thromb Haemost"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.114.304114","article-title":"Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms","volume":"34","author":"Gould","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201901363RRR","article-title":"DNA-Bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: Proof of concept in septic shock plasma","volume":"33","author":"Cruz","year":"2019","journal-title":"FASEB J"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0000000000000741","article-title":"Neutrophil extracellular traps promote hypercoagulability in patients with sepsis","volume":"47","author":"Yang","year":"2017","journal-title":"Shock"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-343061","article-title":"Extracellular histones promote thrombin generation through platelet-dependent mechanisms: Involvement of platelet Tlr2 and Tlr4","volume":"118","author":"Semeraro","year":"2011","journal-title":"Blood"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04422.x","article-title":"Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein c activation","volume":"9","author":"Ammollo","year":"2011","journal-title":"J Thromb Haemost"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.115.306035","article-title":"Cell-free DNA modulates clot structure and impairs fibrinolysis in sepsis","volume":"35","author":"Gould","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.11.7368","article-title":"C5a and tnf-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome","volume":"180","author":"Kambas","year":"2008","journal-title":"J Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113184","article-title":"Stachydrine exhibits a novel antiplatelet property and ameliorates platelet-mediated thrombo-inflammation","volume":"152","author":"Sun","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.240226","article-title":"Mir-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis","volume":"106","author":"Arroyo","year":"2021","journal-title":"Haematologica"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2019.1704711","article-title":"Inhibition of immunothrombosis does not affect pathogen capture and does not promote bacterial dissemination in a mouse model of sepsis","volume":"31","author":"Carestia","year":"2020","journal-title":"Platelets"},{"key":"B139","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1038\/s41598-018-22156-5","article-title":"Neutrophil extracellular trap-microparticle complexes enhance thrombin generation Via the intrinsic pathway of coagulation in mice","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam8897","article-title":"Host dnases prevent vascular occlusion by neutrophil extracellular traps","volume":"358","author":"Jim\u00e9nez-Alc\u00e1zar","year":"2017","journal-title":"Science"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity Via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2053","article-title":"Extracellular histones are major mediators of death in sepsis","volume":"15","author":"Xu","year":"2009","journal-title":"Nat Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/bjh.17503","article-title":"Alpha-defensins: Risk factor for thrombosis in covid-19 infection","volume":"194","author":"Abdeen","year":"2021","journal-title":"Br J Haematol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0000000000000719","article-title":"Evidence of netosis in septic shock-induced disseminated intravascular coagulation","volume":"47","author":"Delabranche","year":"2017","journal-title":"Shock"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1042\/cs20150591","article-title":"Potent irreversible P2y12 inhibition does not reduce lps-induced coagulation activation in a randomized, double-blind, placebo-controlled trial","volume":"130","author":"Schoergenhofer","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"von Br\u00fchl","year":"2012","journal-title":"J Exp Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-722298","article-title":"In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps","volume":"129","author":"Noubouossie","year":"2017","journal-title":"Blood"},{"key":"B148","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13054-018-2109-7","article-title":"Plasma myeloperoxidase-conjugated DNA level predicts outcomes and organ dysfunction in patients with septic shock","volume":"22","author":"Maruchi","year":"2018","journal-title":"Crit Care"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-437772","article-title":"Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation","volume":"120","author":"Darbousset","year":"2012","journal-title":"Blood"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01968.x","article-title":"Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation","volume":"4","author":"Maugeri","year":"2006","journal-title":"J Thromb Haemost"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00385","article-title":"The emerging role of neutrophils in thrombosis-the journey of tf through nets","volume":"3","author":"Kambas","year":"2012","journal-title":"Front Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613934","article-title":"Induction of tissue factor expression in whole blood: Lack of evidence for the presence of tissue factor expression in granulocytes","volume":"83","author":"Osterud","year":"2000","journal-title":"Thromb Haemost"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0000000000000815","article-title":"Pathological role and diagnostic value of endogenous host defense peptides in adult and neonatal sepsis: A systematic review","volume":"47","author":"Ho","year":"2017","journal-title":"Shock"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-861237","article-title":"Neutrophil \u03b1-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability","volume":"133","author":"Abu-Fanne","year":"2019","journal-title":"Blood"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045427","article-title":"Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis","volume":"7","author":"Kambas","year":"2012","journal-title":"PloS One"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02604.x","article-title":"Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: Physiologic and pathologic implications","volume":"5","author":"Bajaj","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.04.207","article-title":"Protein disulfide isomerase enhances tissue factor-dependent thrombin generation","volume":"501","author":"Chen","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1095","article-title":"Tissue-Factor-Bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation","volume":"106","author":"Del Conde","year":"2005","journal-title":"Blood"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.1.170","article-title":"Transfer of tissue factor from leukocytes to platelets is mediated by Cd15 and tissue factor","volume":"96","author":"Rauch","year":"2000","journal-title":"Blood"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0145","article-title":"Characterization of monocyte tissue factor activity induced by igg antiphospholipid antibodies and inhibition by dilazep","volume":"104","author":"Zhou","year":"2004","journal-title":"Blood"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-259267","article-title":"Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice","volume":"116","author":"Pawlinski","year":"2010","journal-title":"Blood"},{"key":"B162","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.immuni.2019.11.005","article-title":"Bacterial endotoxin activates the coagulation cascade through gasdermin d-dependent phosphatidylserine exposure","volume":"51","author":"Yang","year":"2019","journal-title":"Immunity"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.immuni.2019.04.003","article-title":"Inflammasome activation triggers blood clotting and host death through pyroptosis","volume":"50","author":"Wu","year":"2019","journal-title":"Immunity"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3567","article-title":"Tissue factor activity in whole blood","volume":"105","author":"Butenas","year":"2005","journal-title":"Blood"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-007-0667-y","article-title":"Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation","volume":"102","author":"K\u00e4lsch","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1042\/bcj20210522","article-title":"Immunothrombosis and the molecular control of tissue factor by pyroptosis: Prospects for new anticoagulants","volume":"479","author":"Ryan","year":"2022","journal-title":"Biochem J"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001400","article-title":"Acid sphingomyelinase plays a critical role in lps- and cytokine-induced tissue factor procoagulant activity","volume":"134","author":"Wang","year":"2019","journal-title":"Blood"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149410","article-title":"Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities","volume":"52","author":"Ryan","year":"2022","journal-title":"Eur J Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655767","article-title":"Inhibition of protease-activated receptor (Par1) reduces activation of the endothelium, coagulation, fibrinolysis and inflammation during human endotoxemia","volume":"118","author":"Schoergenhofer","year":"2018","journal-title":"Thromb Haemost"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1161\/01.Str.0000236638.75591.61","article-title":"Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia","volume":"37","author":"Htun","year":"2006","journal-title":"Stroke"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.107.141515","article-title":"Platelets recruit human dendritic cells Via mac-1\/Jam-C interaction and modulate dendritic cell function in vitro","volume":"27","author":"Langer","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"154157","DOI":"10.1016\/j.cyto.2017.09.013","article-title":"Platelet-derived chemokines in inflammation and atherosclerosis","volume":"122","author":"Bakogiannis","year":"2019","journal-title":"Cytokine"},{"key":"B173","doi-asserted-by":"publisher","first-page":"13536","DOI":"10.1038\/s41598-018-31910-8","article-title":"Platelet activation and prothrombotic properties in a mouse model of peritoneal sepsis","volume":"8","author":"Vardon Bounes","year":"2018","journal-title":"Sci Rep"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2018.1430355","article-title":"Circulating progenitor cells and their interaction with platelets in patients with an acute coronary syndrome","volume":"30","author":"Tatsidou","year":"2019","journal-title":"Platelets"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht448","article-title":"Expression of stromal cell-derived factor-1 receptors Cxcr4 and Cxcr7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery","volume":"35","author":"Rath","year":"2014","journal-title":"Eur Heart J"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht131","article-title":"Circulating platelet-progenitor cell coaggregate formation is increased in patients with acute coronary syndromes and augments recruitment of Cd34+ cells in the ischaemic microcirculation","volume":"34","author":"Stellos","year":"2013","journal-title":"Eur Heart J"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2011.06.019","article-title":"Association of platelet-Sdf-1 with hemodynamic function and infarct size using cardiac Mr in patients with Ami","volume":"81","author":"Geisler","year":"2012","journal-title":"Eur J Radiol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn566","article-title":"Expression of stromal-Cell-Derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of Cd34+ progenitor cells","volume":"30","author":"Stellos","year":"2009","journal-title":"Eur Heart J"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03659.x","article-title":"Platelet-bound p-selectin expression in patients with coronary artery disease: Impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication","volume":"8","author":"Stellos","year":"2010","journal-title":"J Thromb Haemost"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2010.140","article-title":"Predictive value of platelet activation for the rate of cognitive decline in alzheimer's disease patients","volume":"30","author":"Stellos","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-010-0179-x","article-title":"Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after pci: Prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions","volume":"99","author":"Geisler","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1625","article-title":"Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation","volume":"30","author":"Geisler","year":"2007","journal-title":"Diabetes Care"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620943300","article-title":"Biomarkers of platelet activation and their prognostic value in patients with sepsis-associated disseminated intravascular coagulopathy","volume":"27","author":"Wegrzyn","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02400","article-title":"Platelets and intravascular immunity: Guardians of the vascular space during bloodstream infections and sepsis","volume":"10","author":"McDonald","year":"2019","journal-title":"Front Immunol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091507","article-title":"Platelet versus megakaryocyte: Who is the real bandleader of thromboinflammation in sepsis","volume":"11","author":"Garcia","year":"2022","journal-title":"Cells"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2017.1420152","article-title":"Mucor circinelloides induces platelet aggregation through integrin \u03b1iib\u03b23 and fc\u03b3riia","volume":"30","author":"Ghuman","year":"2019","journal-title":"Platelets"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185431","article-title":"Human platelet interaction with e. coli O111 promotes tissue-Factor-Dependent procoagulant activity, involving toll like receptor 4","volume":"12","author":"Matus","year":"2017","journal-title":"PloS One"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-540526","article-title":"Amplification of bacteria-induced platelet activation is triggered by fc\u03b3riia, integrin \u03b1iib\u03b23, and platelet factor 4","volume":"123","author":"Arman","year":"2014","journal-title":"Blood"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12175","article-title":"Glycoprotein ib\u03b1 and fc\u03b3riia play key roles in platelet activation by the colonizing bacterium, streptococcus oralis","volume":"11","author":"Tilley","year":"2013","journal-title":"J Thromb Haemost"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1160\/th11-12-0891","article-title":"Fibrin formation by staphylothrombin facilitates staphylococcus aureus-induced platelet aggregation","volume":"107","author":"Vanassche","year":"2012","journal-title":"Thromb Haemost"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04208.x","article-title":"The septic milieu triggers expression of spliced tissue factor mrna in human platelets","volume":"9","author":"Rondina","year":"2011","journal-title":"J Thromb Haemost"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04093.x","article-title":"Invasive streptococcus pneumoniae trigger platelet activation Via toll-like receptor 2","volume":"8","author":"Keane","year":"2010","journal-title":"J Thromb Haemost"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.036673-0","article-title":"Direct interaction of iron-regulated surface determinant isdb of staphylococcus aureus with the Gpiib\/Iiia receptor on platelets","volume":"156","author":"Miajlovic","year":"2010","journal-title":"Microbiol (Reading)"},{"key":"B194","doi-asserted-by":"publisher","first-page":"7997","DOI":"10.4049\/jimmunol.0802884","article-title":"Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation Via Tlr4\/Myd88 and the cgmp-dependent protein kinase pathway","volume":"182","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00909-07","article-title":"Role of streptococcus gordonii surface proteins Sspa\/Sspb and hsa in platelet function","volume":"75","author":"Kerrigan","year":"2007","journal-title":"Infect Immun"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2002.02935.x","article-title":"Multiple mechanisms for the activation of human platelet aggregation by staphylococcus aureus: Roles for the clumping factors clfa and clfb, the serine-aspartate repeat protein sdre and protein a","volume":"44","author":"O'Brien","year":"2002","journal-title":"Mol Microbiol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v100.2.509","article-title":"A role for glycoprotein ib in streptococcus sanguis-induced platelet aggregation","volume":"100","author":"Kerrigan","year":"2002","journal-title":"Blood"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v97.12.3790","article-title":"Activation of protease-activated receptors by gingipains from porphyromonas gingivalis leads to platelet aggregation: A new trait in microbial pathogenicity","volume":"97","author":"Lourbakos","year":"2001","journal-title":"Blood"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.897019","article-title":"Neutrophil extracellular traps induced by shiga toxin and lipopolysaccharide-treated platelets exacerbate endothelial cell damage","volume":"12","author":"Landoni","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B200","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2018.06.017","article-title":"\u03b1-toxin induces platelet aggregation and liver injury during staphylococcus aureus sepsis","volume":"24","author":"Surewaard","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with covid-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.111.244707","article-title":"Binding of oxidized low-density lipoprotein on circulating platelets is increased in patients with acute coronary syndromes and induces platelet adhesion to vascular wall in vivo\u2013brief report","volume":"32","author":"Stellos","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810900","article-title":"The controversial role of lps in platelet activation in vitro","volume":"23","author":"Galgano","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00085","article-title":"Cell type-specific roles of nf-\u03bab linking inflammation and thrombosis","volume":"10","author":"Mussbacher","year":"2019","journal-title":"Front Immunol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(16)30355-3","article-title":"Platelets and coagulation in thrombus formation: Aberrations in the Scott syndrome","volume":"141","author":"van Geffen","year":"2016","journal-title":"Thromb Res"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.11.001","article-title":"Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo","volume":"139","author":"M\u00fcller","year":"2009","journal-title":"Cell"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.118.036323","article-title":"Platelet protein disulfide isomerase promotes glycoprotein ib\u03b1-mediated platelet-neutrophil interactions under thromboinflammatory conditions","volume":"139","author":"Li","year":"2019","journal-title":"Circulation"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2013.1466","article-title":"Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: A prospective clinical study","volume":"7","author":"Liu","year":"2014","journal-title":"Exp Ther Med"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819c06bc","article-title":"Unfractioned heparin for treatment of sepsis: A randomized clinical trial (the hetrase study)","volume":"37","author":"Jaimes","year":"2009","journal-title":"Crit Care Med"},{"key":"B210","article-title":"Venous thromboembolism in critically ill patients. observations from a randomized trial in sepsis","volume":"101","author":"Shorr","year":"2009","journal-title":"Thromb Haemost"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200612-1803OC","article-title":"Prophylactic heparin in patients with severe sepsis treated with drotrecogin Alfa (Activated)","volume":"176","author":"Levi","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.100.25.2485","article-title":"Heparin blunts endotoxin-induced coagulation activation","volume":"100","author":"Pernerstorfer","year":"1999","journal-title":"Circulation"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1007\/s001010050455","article-title":"D-dimer, thrombin-antithrombin iii-complex (Tat) and prothrombin fragment 1+2 (Ptf). parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders","volume":"46","author":"Hofmann","year":"1997","journal-title":"Anaesthesist"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.3109\/inf.1971.3.issue-2.06","article-title":"Fulminant meningococcemia. heparin therapy and survival rate","volume":"3","author":"Manios","year":"1971","journal-title":"Scand J Infect Dis"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.115.306528","article-title":"Platelet P2y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model","volume":"35","author":"Thomas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13054-019-2573-8","article-title":"Co-Administration of iloprost and eptifibatide in septic shock (Co-ilepss)-a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy","volume":"23","author":"Berthelsen","year":"2019","journal-title":"Crit Care"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1160\/th03-04-0233","article-title":"Blockade of Gpiib\/Iiia by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia","volume":"90","author":"Derhaschnig","year":"2003","journal-title":"Thromb Haemost"},{"key":"B218","first-page":"39","article-title":"Therapy with high-doses of antithrombin iii in patients with septic shock and agranulocytosis","volume":"59","author":"Galstian","year":"2014","journal-title":"Anesteziol Reanimatol"},{"key":"B219","doi-asserted-by":"publisher","first-page":"R297","DOI":"10.1186\/cc13163","article-title":"A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis","volume":"17","author":"Gando","year":"2013","journal-title":"Crit Care"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1160\/TH05-07-0530","article-title":"Benefit\/Risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin","volume":"95","author":"Hoffmann","year":"2006","journal-title":"Thromb Haemost"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01697.x","article-title":"Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation","volume":"4","author":"Kienast","year":"2006","journal-title":"J Thromb Haemost"},{"key":"B222","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clpt.2005.10.003","article-title":"Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia","volume":"79","author":"Leitner","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"B223","doi-asserted-by":"publisher","first-page":"R160","DOI":"10.1186\/cc5098","article-title":"Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis","volume":"10","author":"Gonano","year":"2006","journal-title":"Crit Care"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000139691.54108.1f","article-title":"Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis","volume":"32","author":"Hoffmann","year":"2004","journal-title":"Crit Care Med"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. high-dose antithrombin iii in severe sepsis: A randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"Jama"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050642","article-title":"Antithrombin iii in patients with severe sepsis. a randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin iii in severe sepsis","volume":"24","author":"Eisele","year":"1998","journal-title":"Intensive Care Med"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199808000-00002","article-title":"Effect of antithrombin iii supplementation on inflammatory response in patients with severe sepsis","volume":"10","author":"Inthorn","year":"1998","journal-title":"Shock"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199711000-00003","article-title":"Antithrombin iii supplementation in severe sepsis: Beneficial effects on organ dysfunction","volume":"8","author":"Inthorn","year":"1997","journal-title":"Shock"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.3.882","article-title":"Double-blind, placebo-controlled trial of antithrombin iii concentrates in septic shock with disseminated intravascular coagulation","volume":"104","author":"Fourrier","year":"1993","journal-title":"Chest"},{"key":"B230","doi-asserted-by":"publisher","first-page":"11136","DOI":"10.1038\/s41598-019-47630-6","article-title":"Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers","volume":"9","author":"Schoergenhofer","year":"2019","journal-title":"Sci Rep"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221077096","article-title":"Benefit profile of thrombomodulin Alfa combined with antithrombin concentrate in patients with sepsis-induced disseminated intravascular coagulation","volume":"28","author":"Murao","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620981630","article-title":"Comparison of protective effects of recombinant antithrombin gamma and plasma-derived antithrombin on sepsis-induced disseminated intravascular coagulation and multiple organ failure","volume":"26","author":"Kuroda","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"B233","doi-asserted-by":"publisher","first-page":"16626","DOI":"10.1038\/s41598-019-52968-y","article-title":"Effect of high-dose antithrombin supplementation in patients with septic shock and disseminated intravascular coagulation","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1177\/1076029618757346","article-title":"Optimal antithrombin activity threshold for initiating antithrombin supplementation in patients with sepsis-induced disseminated intravascular coagulation: A multicenter retrospective observational study","volume":"24","author":"Hayakawa","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1160\/th15-01-0053","article-title":"Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis","volume":"114","author":"Tagami","year":"2015","journal-title":"Thromb Haemost"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12643","article-title":"Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: An observational nationwide study","volume":"12","author":"Tagami","year":"2014","journal-title":"J Thromb Haemost"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e318184621d","article-title":"Early administration of high-dose antithrombin in severe sepsis: Single center results from the kybersept-trial","volume":"107","author":"Eid","year":"2008","journal-title":"Anesth Analg"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1007\/pl00014353","article-title":"Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency\u2013a feasibility pilot study","volume":"158","author":"Kreuz","year":"1999","journal-title":"Eur J Pediatr"},{"key":"B239","volume-title":"Antithrombin (Recombinant)","year":"2009"},{"key":"B240","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: The scarlet randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"Jama"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012850","article-title":"Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: A single-centre, open-label, randomised controlled trial","volume":"6","author":"Hagiwara","year":"2016","journal-title":"BMJ Open"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized, double-blind, placebo-controlled, phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, art-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit Care Med"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-016-4405-5","article-title":"Protein c zymogen in severe sepsis: A double-blinded, placebo-controlled, randomized study","volume":"42","author":"Pappalardo","year":"2016","journal-title":"Intensive Care Med"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin Alfa (Activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-009-1436-1","article-title":"Extended drotrecogin Alfa (Activated) treatment in patients with prolonged septic shock","volume":"35","author":"Dhainaut","year":"2009","journal-title":"Intensive Care Med"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)60411-5","article-title":"Drotrecogin Alfa (Activated) in children with severe sepsis: A multicentre phase iii randomised controlled trial","volume":"369","author":"Nadel","year":"2007","journal-title":"Lancet"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050935","article-title":"Drotrecogin Alfa (Activated) for adults with severe sepsis and a low risk of death","volume":"353","author":"Abraham","year":"2005","journal-title":"N Engl J Med"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200411-1483OC","article-title":"Activated protein c inhibits local coagulation after intrapulmonary delivery of endotoxin in humans","volume":"171","author":"van der Poll","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000116778.27924.79","article-title":"Effects of drotrecogin Alfa (Activated) in human endotoxemia","volume":"21","author":"Kalil","year":"2004","journal-title":"Shock"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1086\/375775","article-title":"Drotrecogin Alfa (Activated) treatment of older patients with severe sepsis","volume":"37","author":"Ely","year":"2003","journal-title":"Clin Infect Dis"},{"key":"B251","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/nejm200103083441001","article-title":"Efficacy and safety of recombinant human activated protein c for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (Recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"Jama"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200111000-00007","article-title":"Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study","volume":"29","author":"Abraham","year":"2001","journal-title":"Crit Care Med"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.4.1124.002k20_1124_1129","article-title":"Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia","volume":"95","author":"de Jonge","year":"2000","journal-title":"Blood"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0b013e318142c4e8","article-title":"Effects of the pan-selectin antagonist bimosiamose (Tbc1269) in experimental human endotoxemia","volume":"29","author":"Mayr","year":"2008","journal-title":"Shock"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000126265.08175.be","article-title":"Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia","volume":"32","author":"Derhaschnig","year":"2004","journal-title":"Crit Care Med"},{"key":"B257","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1086\/346043","article-title":"Effects of Ic14, an anti-Cd14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans","volume":"187","author":"Verbon","year":"2003","journal-title":"J Infect Dis"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.127740","article-title":"Pharmacodynamics of active site-inhibited factor viia in endotoxin-induced coagulation in humans","volume":"72","author":"Jilma","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.2701","article-title":"Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia","volume":"89","author":"Pajkrt","year":"1997","journal-title":"Blood"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211050356","article-title":"Effect of recombinant human soluble thrombomodulin on coagulation-related variables in patients with sepsis-induced disseminated intravascular coagulation: A retrospective observational study","volume":"27","author":"Mitaka","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000004426","article-title":"Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with sepsis-associated coagulopathy","volume":"48","author":"Levi","year":"2020","journal-title":"Crit Care Med"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.12.025","article-title":"Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis","volume":"176","author":"Ogura","year":"2019","journal-title":"Thromb Res"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0000000000001148","article-title":"Recombinant human-soluble thrombomodulin contributes to reduced mortality in sepsis patients with severe respiratory failure: A retrospective observational study using a multicenter dataset","volume":"51","author":"Yoshihiro","year":"2019","journal-title":"Shock"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1160\/th15-12-0987","article-title":"Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study","volume":"115","author":"Hayakawa","year":"2016","journal-title":"Thromb Haemost"},{"key":"B265","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcrc.2016.06.008","article-title":"The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation","volume":"36","author":"Yasuda","year":"2016","journal-title":"J Crit Care"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-013-2822-2","article-title":"Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: A multicenter propensity score analysis","volume":"39","author":"Yamakawa","year":"2013","journal-title":"Intensive Care Med"},{"key":"B267","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1186\/cc10228","article-title":"Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: A historical control study","volume":"15","author":"Yamakawa","year":"2011","journal-title":"Crit Care"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31825fd6d9","article-title":"Activated protein c and septic shock: A propensity-matched cohort study*","volume":"40","author":"Rimmer","year":"2012","journal-title":"Crit Care Med"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e318250ad48","article-title":"Biomarker response to drotrecogin Alfa (Activated) in children with severe sepsis: Results from the resolve clinical trial*","volume":"13","author":"Dalton","year":"2012","journal-title":"Pediatr Crit Care Med"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e3181e7623e","article-title":"Protein c concentrate as adjuvant treatment in neonates with sepsis-induced coagulopathy: A pilot study","volume":"34","author":"Decembrino","year":"2010","journal-title":"Shock"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-009-1584-3","article-title":"Human protein c zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery","volume":"35","author":"Crivellari","year":"2009","journal-title":"Intensive Care Med"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1097\/01.Ccm.0000051515.56179.E1","article-title":"Effects of drotrecogin Alfa (Activated) on organ dysfunction in the prowess trial","volume":"31","author":"Vincent","year":"2003","journal-title":"Crit Care Med"},{"key":"B273","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13054-016-1415-1","article-title":"Benefit profile of anticoagulant therapy in sepsis: A nationwide multicentre registry in Japan","volume":"20","author":"Yamakawa","year":"2016","journal-title":"Crit Care"},{"key":"B274","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40560-021-00555-7","article-title":"The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-sscg 2020)","volume":"9","author":"Egi","year":"2021","journal-title":"J Intensive Care"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13950","article-title":"Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: Meta-analyses revisited","volume":"16","author":"Wiedermann","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14812","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis","volume":"18","author":"Valeriani","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B277","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0038-1676345","article-title":"Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: An updated systematic review and meta-analysis","volume":"119","author":"Yamakawa","year":"2019","journal-title":"Thromb Haemost"},{"key":"B278","doi-asserted-by":"publisher","first-page":"Cd004388","DOI":"10.1002\/14651858.CD004388.pub5","article-title":"Human recombinant activated protein c for severe sepsis","volume":"3","author":"Mart\u00ed-Carvajal","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1038\/srep25984","article-title":"Efficacy and safety of low-Molecular-Weight heparin in patients with sepsis: A meta-analysis of randomized controlled trials","volume":"6","author":"Fan","year":"2016","journal-title":"Sci Rep"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-021-01545-w","article-title":"Unfractionated heparin improves the clinical efficacy in adult sepsis patients: A systematic review and meta-analysis","volume":"22","author":"Fu","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-169","article-title":"Therapeutic effect of low-Molecular-Weight heparin on adult sepsis: A meta-analysis","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(20)30411-2","article-title":"Effect of aspirin on deaths associated with sepsis in healthy older people (Antisepsis): A randomised, double-blind, placebo-controlled primary prevention trial","volume":"9","author":"Eisen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1022985","article-title":"Forsythiaside b ameliorates coagulopathies in a rat model of sepsis through inhibition of the formation of Pad4-dependent neutrophil extracellular traps","volume":"13","author":"He","year":"2022","journal-title":"Front Pharmacol"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2021.10.039","article-title":"Reduction of netosis by targeting Cxcr1\/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis","volume":"128","author":"Alsabani","year":"2022","journal-title":"Br J Anaesth"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15162","article-title":"Cd14 inhibition improves survival and attenuates thrombo-inflammation and cardiopulmonary dysfunction in a baboon model of escherichia coli sepsis","volume":"19","author":"Keshari","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3827501","article-title":"Lidocaine alleviates sepsis-induced acute lung injury in mice by suppressing tissue factor and matrix metalloproteinase-2\/9","volume":"2021","author":"Zheng","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112473","article-title":"Targeting Anxa1\/Formyl peptide receptor 2 pathway affords protection against pathological thrombo-inflammation","volume":"9","author":"Vital","year":"2020","journal-title":"Cells"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234039","article-title":"Nlrp3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture","volume":"15","author":"Cornelius","year":"2020","journal-title":"PloS One"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002282","article-title":"The role of type 1 interferons in coagulation induced by gram-negative bacteria","volume":"135","author":"Yang","year":"2020","journal-title":"Blood"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00795-7","article-title":"Extracellular Sqstm1 mediates bacterial septic death in mice through insulin receptor signalling","volume":"5","author":"Zhou","year":"2020","journal-title":"Nat Microbiol"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110528","article-title":"Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis","volume":"130","author":"Wang","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0000000000001146","article-title":"Amitriptyline treatment mitigates sepsis-induced tumor necrosis factor expression and coagulopathy","volume":"51","author":"Xia","year":"2019","journal-title":"Shock"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13549","article-title":"Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice","volume":"174","author":"Steven","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.06.003","article-title":"Histidine-rich glycoprotein prevents septic lethality through regulation of immunothrombosis and inflammation","volume":"9","author":"Wake","year":"2016","journal-title":"EBioMedicine"},{"key":"B295","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.imbio.2015.04.002","article-title":"Organ inflammation in porcine escherichia coli sepsis is markedly attenuated by combined inhibition of C5 and Cd14","volume":"220","author":"Egge","year":"2015","journal-title":"Immunobiology"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0000000000000396","article-title":"Delayed but not early treatment with dnase reduces organ damage and improves outcome in a murine model of sepsis","volume":"44","author":"Mai","year":"2015","journal-title":"Shock"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201909","article-title":"Combined inhibition of complement C5 and Cd14 markedly attenuates inflammation, thrombogenicity, and hemodynamic changes in porcine sepsis","volume":"191","author":"Barratt-Due","year":"2013","journal-title":"J Immunol"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-140798","article-title":"Cd14 inhibition efficiently attenuates early inflammatory and hemostatic responses in escherichia coli sepsis in pigs","volume":"24","author":"Thorgersen","year":"2010","journal-title":"FASEB J"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcma.2013.05.004","article-title":"Plasma levels in sepsis patients of annexin A1, lipoxin A4, macrophage inflammatory protein-3a, and neutrophil gelatinase-associated lipocalin","volume":"76","author":"Tsai","year":"2013","journal-title":"J Chin Med Assoc"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14073","article-title":"Nlrp3 inflammasome activation in platelets in response to sepsis","volume":"7","author":"Cornelius","year":"2019","journal-title":"Physiol Rep"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0","article-title":"The Nlrp3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0000000000001804","article-title":"Mechanistic studies of dnase I activity: Impact of heparin variants and Pad4","volume":"56","author":"Sohrabipour","year":"2021","journal-title":"Shock"},{"key":"B303","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/cc11442","article-title":"Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice","volume":"16","author":"Meng","year":"2012","journal-title":"Crit Care"},{"key":"B304","unstructured":"Intravenous dnase I for the treatment of sepsis (Idealsepsisi)2022"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90224-6","article-title":"Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis","volume":"86","author":"Hack","year":"1989","journal-title":"Am J Med"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.1056\/nejm197512112932416","article-title":"Letter: Complement activation in septic shock","volume":"293","author":"Robin","year":"1975","journal-title":"N Engl J Med"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15062","article-title":"Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways","volume":"180","author":"Keragala","year":"2018","journal-title":"Br J Haematol"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and coagulation: Strangers or partners in crime","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1144229\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T01:28:25Z","timestamp":1680571705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1144229\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":308,"alternative-id":["10.3389\/fimmu.2023.1144229"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1144229","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"article-number":"1144229"}}